Addus EVP logs stock grant and tax-driven sale

Addus HomeCare Corp EVP and Chief HR Officer Roberton James Stevenson reported a stock grant and a related share sale.

Rhea-AI Filing Summary

Addus HomeCare Corp EVP and Chief HR Officer Roberton James Stevenson reported a stock grant and a related share sale. On February 20, he acquired 2,858 shares of common stock as a grant, at no cost, which vest in equal installments on February 20 of 2027, 2028, and 2029, subject to continued service and potential acceleration upon a change in control. On February 23, he sold 561 shares at $114.91 per share under a pre-set Rule 10b5-1 plan to cover tax obligations from vesting restricted stock awards, leaving 14,881 shares directly owned.

Insider Trade Summary

Net Seller: 561 shares

Net Sell 2 txns

Insider Stevenson Roberton James

Role EVP, Chief HR Officer

Sold 561 shs ($64K)

Type	Security	Shares	Price	Value
Sale	Common Stock	561	$114.91	$64K
Grant/Award	Common Stock	2,858	$0.00	$0.00

Holdings After Transaction: Common Stock — 14,881 shares (Direct)

Footnotes (3)

1. F1. The shares vest in equal installments on each of February 20, 2027, February 20, 2028, and February 20, 2029, subject to customary provisions for continued service and acceleration on a change in control.
2. F2. This transaction reflects the sale of shares, made pursuant to a previously established 10b5-1 plan, for the purpose of satisfying tax obligations due upon the vesting of restricted stock awards granted by the Issuer.
3. F3. Adoption date of referenced 10b5-1(c) plan is: 03/05/2025

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Addus HomeCare (ADUS) report for Roberton James Stevenson?

Roberton James Stevenson reported both a stock grant and a small share sale. He received 2,858 common shares as an award and sold 561 shares at $114.91 per share, leaving 14,881 shares directly owned after the transactions.

Was the Addus HomeCare (ADUS) insider share sale part of a 10b5-1 trading plan?

Yes, the reported share sale was executed under a pre-established Rule 10b5-1 plan. The footnote states the sale was made pursuant to this plan to satisfy tax obligations tied to vesting restricted stock awards.

Why did the Addus HomeCare (ADUS) executive sell 561 shares of common stock?

The 561-share sale was to cover tax obligations from vesting restricted stock awards. The filing explains the sale occurred under a pre-set Rule 10b5-1 plan specifically for satisfying those tax liabilities.

How many Addus HomeCare (ADUS) shares does the executive own after these Form 4 transactions?

After the reported transactions, the executive directly owns 14,881 common shares. This figure reflects the impact of the 2,858-share grant on February 20 and the 561-share sale on February 23 as disclosed.

How does the new Addus HomeCare (ADUS) stock grant vest for the executive?

The 2,858-share grant vests in three equal annual installments. Vesting occurs on February 20 of 2027, 2028, and 2029, and is subject to continued service and possible acceleration upon a change in control.

When was the Rule 10b5-1 plan for the Addus HomeCare (ADUS) insider sale adopted?

The Rule 10b5-1(c) trading plan was adopted on March 5, 2025. The filing’s footnote specifies this adoption date in connection with the 561-share sale used to cover tax obligations.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/24/2026 - 04:02 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Stevenson Roberton James

(Last) (First) (Middle)

6303 COWBOYS WAY

SUITE 600

(Street)

FRISCO TX 75034

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Addus HomeCare Corp [ ADUS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief HR Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/20/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/20/2026		A		2,858(1)	A	$0	15,442	D
Common Stock	02/23/2026		S(2)(3)		561	D	$114.91	14,881	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares vest in equal installments on each of February 20, 2027, February 20, 2028, and February 20, 2029, subject to customary provisions for continued service and acceleration on a change in control.

2. This transaction reflects the sale of shares, made pursuant to a previously established 10b5-1 plan, for the purpose of satisfying tax obligations due upon the vesting of restricted stock awards granted by the Issuer.

3. Adoption date of referenced 10b5-1(c) plan is: 03/05/2025

	/s/ Brian Poff, Attorney-in-Fact for Roberton James Stevenson	02/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.